-
Je něco špatně v tomto záznamu ?
Detection of prions in matching post-mortem skin and cerebrospinal fluid samples using second-generation real-time quaking-induced conversion assay
S. Baranová, T. Moško, M. Brůžová, T. Haldiman, C. Kim, JG. Safar, R. Matěj, K. Holada
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
R01 NS074317
NINDS NIH HHS - United States
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- biotest MeSH
- Creutzfeldtova-Jakobova nemoc * diagnóza mozkomíšní mok MeSH
- kůže metabolismus MeSH
- lidé MeSH
- prionová bílkovina MeSH
- prionové nemoci * diagnóza MeSH
- priony * metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Real-time quaking-induced conversion assay (RT-QuIC) exploits templating activity of pathogenic prion protein for ultrasensitive detection of prions. We have utilized second generation RT-QuIC assay to analyze matching post-mortem cerebrospinal fluid and skin samples of 38 prion disease patients and of 30 deceased neurological controls. The analysis of cerebrospinal fluid samples led to 100% sensitivity and 100% specificity, but some samples had to be diluted before the analysis to alleviate the effect of present RT-QuIC inhibitors. The analysis of the corresponding skin samples provided 89.5% sensitivity and 100% specificity. The median seeding dose present in the skin was one order of magnitude higher than in the cerebrospinal fluid, despite the overall fluorescent signal of the skin samples was comparatively lower. Our data support the use of post-mortem cerebrospinal fluid for confirmation of prion disease diagnosis and encourage further studies of the potential of skin biopsy samples for intra-vitam prion diseases ́ diagnostics.
Department Neurology Case Western Reserve University School of Medicine Cleveland OH 44106 USA
Department of Pathology Case Western Reserve University School of Medicine Cleveland OH 44106 USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006716
- 003
- CZ-PrNML
- 005
- 20240516115717.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-024-56789-6 $2 doi
- 035 __
- $a (PubMed)38491063
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Baranová, Soňa $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0317357
- 245 10
- $a Detection of prions in matching post-mortem skin and cerebrospinal fluid samples using second-generation real-time quaking-induced conversion assay / $c S. Baranová, T. Moško, M. Brůžová, T. Haldiman, C. Kim, JG. Safar, R. Matěj, K. Holada
- 520 9_
- $a Real-time quaking-induced conversion assay (RT-QuIC) exploits templating activity of pathogenic prion protein for ultrasensitive detection of prions. We have utilized second generation RT-QuIC assay to analyze matching post-mortem cerebrospinal fluid and skin samples of 38 prion disease patients and of 30 deceased neurological controls. The analysis of cerebrospinal fluid samples led to 100% sensitivity and 100% specificity, but some samples had to be diluted before the analysis to alleviate the effect of present RT-QuIC inhibitors. The analysis of the corresponding skin samples provided 89.5% sensitivity and 100% specificity. The median seeding dose present in the skin was one order of magnitude higher than in the cerebrospinal fluid, despite the overall fluorescent signal of the skin samples was comparatively lower. Our data support the use of post-mortem cerebrospinal fluid for confirmation of prion disease diagnosis and encourage further studies of the potential of skin biopsy samples for intra-vitam prion diseases ́ diagnostics.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a priony $x metabolismus $7 D011328
- 650 12
- $a prionové nemoci $x diagnóza $7 D017096
- 650 _2
- $a kůže $x metabolismus $7 D012867
- 650 _2
- $a prionová bílkovina $7 D000072002
- 650 _2
- $a biotest $7 D001681
- 650 12
- $a Creutzfeldtova-Jakobova nemoc $x diagnóza $x mozkomíšní mok $7 D007562
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Moško, Tibor $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Brůžová, Magdalena $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Haldiman, Tracy $u Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA $u Department Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA
- 700 1_
- $a Kim, Chae $u Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA $u Department Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA
- 700 1_
- $a Safar, Jiri G $u Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA $u Department Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA
- 700 1_
- $a Matěj, Radoslav $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Holada, Karel $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. karel.holada@lf1.cuni.cz
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 6294
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38491063 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240516115711 $b ABA008
- 999 __
- $a ok $b bmc $g 2080985 $s 1216483
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 14 $c 1 $d 6294 $e 20240315 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a R01 NS074317 $p NINDS NIH HHS $2 United States
- LZP __
- $a Pubmed-20240412